Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis.

Ji F, Zheng L, Chen D, Xia P, Zou Z, Liu W, Bugno J, Naccasha EZ, Piffkó A, Wen C, Li K, Xu L, Luo SZ, Huang X, Wang J, Ju C, Liu B, Ji Y, Li H, Chmura SJ, Pitroda SP, Liang HL, He C, Weichselbaum RR.

Open source

DOI
10.1016/j.ccell.2026.08.017
Published
2026-09-17
Container
Cancer Cell
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ccell.2026.08.017,
  title = {Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis.},
  author = {Ji F and  Zheng L and  Chen D and  Xia P and  Zou Z and  Liu W and  Bugno J and  Naccasha EZ and  Piffkó A and  Wen C and  Li K and  Xu L and  Luo SZ and  Huang X and  Wang J and  Ju C and  Liu B and  Ji Y and  Li H and  Chmura SJ and  Pitroda SP and  Liang HL and  He C and  Weichselbaum RR.},
  year = {2026},
  journal = {Cancer Cell},
  doi = {10.1016/j.ccell.2026.08.017},
  url = {https://doi.org/10.1016/j.ccell.2026.08.017}
}

RIS

TY  - JOUR
TI  - Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis.
AU  - Ji F
AU  -  Zheng L
AU  -  Chen D
AU  -  Xia P
AU  -  Zou Z
AU  -  Liu W
AU  -  Bugno J
AU  -  Naccasha EZ
AU  -  Piffkó A
AU  -  Wen C
AU  -  Li K
AU  -  Xu L
AU  -  Luo SZ
AU  -  Huang X
AU  -  Wang J
AU  -  Ju C
AU  -  Liu B
AU  -  Ji Y
AU  -  Li H
AU  -  Chmura SJ
AU  -  Pitroda SP
AU  -  Liang HL
AU  -  He C
AU  -  Weichselbaum RR.
PY  - 2026
JO  - Cancer Cell
DO  - 10.1016/j.ccell.2026.08.017
UR  - https://doi.org/10.1016/j.ccell.2026.08.017
ER  - 

APA

F, J., L, Z., D, C., P, X., Z, Z., W, L., J, B., EZ, N., A, P., C, W., K, L., L, X., SZ, L., X, H., J, W., C, J., B, L., Y, J., H, L., SJ, C., SP, P., HL, L., C, H., & RR., W. (2026). Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis.. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.08.017

Source records